1 / 68

ONDERSTEPOORT BIOLOGICAL PRODUCTS LTD

ONDERSTEPOORT BIOLOGICAL PRODUCTS LTD. PRESENTATION TO THE PORTFOLIO COMMITTEE: 2 NOVEMBER 2004. PRESENTATION OUTLINE:. Introduction (Mr S C Makama – Board Chairperson) Governance Report (Mr S C Makama – Board Chairperson)

maritzas
Download Presentation

ONDERSTEPOORT BIOLOGICAL PRODUCTS LTD

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. ONDERSTEPOORT BIOLOGICAL PRODUCTS LTD PRESENTATION TO THE PORTFOLIO COMMITTEE: 2 NOVEMBER 2004

  2. PRESENTATION OUTLINE: • Introduction (Mr S C Makama – Board Chairperson) • Governance Report (Mr S C Makama – Board Chairperson) • Company Performance for 2003/04 (Dr L Makuleni – Managing Director) • Human Resource Report (Ms S A Bokwe) • Financial Performance 2003/04 (Mr M P van Jaarsveld – General Manager: Finance) • Conclusion (Dr L Makuleni)

  3. INTRODUCTION

  4. VISION: “To be a centre of excellence in developing, producing and marketing biological products – Serving Africa…Serving the world.”

  5. MISSION : “To translate science into biological products, knowledge and technology - resulting in improved animal health, food security and safety for all our stakeholders”

  6. VALUES: • OBP will conduct business in such a way to ensure: • A high level of integrity; • High ethical standards; • The highest standards of quality; and • Excellence in everything that we do. • We accept that: • People are our major assets; • As a State owned entity we have the responsibility to provide for Public Good; • We have a responsibility to our society and the environment

  7. VALUES: • As a Company we will strive to promote: • Respect for all people; • Animal welfare; • Development of our employees; and • Customer care and satisfaction.

  8. CORPORATE GOVERNANCE:

  9. CORPORATE GOVERNANCE – FUNCTIONING OF BOARD • The Board retains full and effective control of the Company • To this end, the Board met quarterly, and also scheduled 6 additional meetings • The Board is committed towards Good Corporate Governance: • Induction • Director Development Programme • Agreed to assessment of Board and Board Committees

  10. CORPORATE GOVERNANCE – FUNCTIONING OF BOARD COMMITTEES

  11. CORPORATE GOVERNANCE – FUNCTIONING OF BOARD COMMITTEES

  12. CORPORATE GOVERNANCE – FUNCTIONING OF BOARD COMMITTEES

  13. CORPORATE GOVERNANCE – FUNCTIONING OF BOARD COMMITTEES

  14. CORPORATE GOVERNANCE – FUNCTIONING OF BOARD COMMITTEES

  15. COMPANY PERFORMANCE FOR 2003/04

  16. HIGHLIGHTS: Onderstepoort Biological Products Ltd has become a respected leader in its niche market: the production and sale of animal vaccines and related biological products. World export sales are steady and firm; trade with the continent is being stimulated and is increasing while domestic market sales continue to be encouraging.

  17. HIGHLIGHTS: • FINANCIAL • Sales Growth • Domestic • Export • Operational Profits

  18. HIGHLIGHTS: • Sales History

  19. HIGHLIGHTS

  20. HIGHLIGHTS: • Cumulative Sales Income 2003/04

  21. HIGHLIGHTS: • Cumulative Operating Profit 2003/04

  22. HIGHLIGHTS: Our strengthened Research and Development capacity has resulted in OBP having identified and initiated research projects that have led to a number of products in the pipeline.

  23. HIGHLIGHTS: • RESEARCH AND DEVELOPMENT • Broaden Research and Development Partners: • International • Local – Academic Institutions • 3 Research and Development Projects on Trans-Boundary Diseases

  24. HIGHLIGHTS: • RESEARCH AND DEVELOPMENT • Establish and Strengthen Research and Development Capacity • 3 Functional Departments • Increase Number of Scientists • Increase R & D Expenditure (5% of sales)

  25. HIGHLIGHTSSCIENTISTS EQUITY STATUS REPORT 2000 2004

  26. HIGHLIGHTS: The streamlining of production processes has had the effect of improving our production success rate to 90%, as well as improving our production quality, our product availability and thereby ensuring increased customer satisfaction

  27. HIGLIGHTS: • OPERATIONS • Production Success Rate: 75% to 90% • Facility Upgrade • Physical Infrastructure Audit • Facility Upgrade Plan • Streamlining Production Processes • Production Planning Processes

  28. HIGHLIGHTS: The new state-of-the-art small animal holding facility that has been erected is important for facilitating experimental work requiring controlled environment and bio-containment. It will also provide much needed opportunities for international researchers to form partnerships with OBP (Ltd).

  29. EXPERIMENTAL ANIMAL FACILITY:

  30. HIGHLIGHTS: • TOTAL QUALITY MANAGEMENT • Regulatory Affairs • Dossiers submitted • Local • International

  31. HIGHLIGHTS: • TOTAL QUALITY MANAGEMENT • Two new products submitted, and registered • Quality System • Experimental Animal Facility

  32. HUMAN RESOURCE REPORT: 2003/04

  33. HIGHLIGHTS: Our Human Resource Management and Development Policies have enabled OBP to effect a successful restructuring and transformation in terms of representivity and gender especially within the management and decision making cadres.

  34. HIGHLIGHTS: • HUMAN RESOURCE • Staff Compliment – 187 • Human Resource Development • Skills Development • ABET • Bursaries • Multi-skilling • In-House Training • Management Development programme • System and Process in place

  35. COMPANY PERFORMANCE: • EQUITY REPORT: • Executive: 50% Designated group, 40% female) • Management: 69% Designated group, 32 % female) • Scientist: 75%Designated group, 50% female)

  36. EQUITY STATUS REPORTMANAGEMENT LEVEL (2000 vs. 2004) 2000 2004

  37. SKILLS PROFILE:2002/03 PG = Post Graduate

  38. SKILLS PROFILE:2003/04 PG = Post Graduate

  39. Financial results of Onderstepoort Biological Products Ltd 2003/04

  40. Index • Sales • Production • Cost Analysis • Profit • Capital expenditure • Cash position • Balance Sheet

  41. Sales in doses • Budget 95m • Actual 100m • Variance 5m • Percentage +5%

  42. Sales in Rand • Budget R61m • Actual R70m • Variance R9m • Percentage +14%

  43. Local Sales in Rand • Budget R40m • Actual R36m • Variance R4m • Percentage -4%

  44. Export Sales in Rand • Budget R21m • Actual R34m • Variance R13m • Percentage +59%

  45. Expenses • Budget R44m • Actual R36m • Variance R8m • Percentage +19%

More Related